C-6-Ceramide Inhibited Na2+ Currents By Intracellular Ca2+ Release In Rat Myoblasts

Zheng Liu,Jian-Guang Xu,Hua Zhang,Yan-Jia Fang,Yan-Ai Mei

DOI: https://doi.org/10.1002/jcp.21106

2007-01-01

Journal of Cellular Physiology

Abstract:Ceramides are novel second messengers that may mediate signaling leading to apoptosis and the regulation of cell cycle progression. Moreover, ceramide analogs have been reported to directly modulate K+ and Ca2+ channels in different cell types. In this report, the effect of C-6-ceramide on the voltage-gated inward Na+ currents (I-Na) in cultured rat myoblasts was investigated using whole-cell current recording and a fluorescent Ca2+ imaging experiment. At concentrations of 1-100 mu M, ceramide produced a dose-independent and reversible inhibition of I-NA. Ceramide also significantly shifted the steady-state inactivation curve of I-Na by 16 mV toward the hyperpolarizing potential, but did not alter the steady-state activation properties. C-2-ceramide caused a similar inhibitory effect on IN, amplitude. However, dihydro-C-6-ceramide, the inactive analog of ceramide, failed to modulate I-Na. The effect of C-6-ceramide on IN, was abolished by intracellular infusion of the Ca2+-chelating agent BAPTA, but was mimicked by application of caffeine. Blocking the release of Ca2+ from the sarcoplasmic reticulum with xestospongin C or heparin, an inositol 1,4,5-trisphosphate (IP3) receptor blocker, induced a gradual increase in IN, amplitude and eliminated the effect of ceramide on I-Na. In contrast, ruthenium red, which is a blocker of the ryanodine-sensitive Ca2+ receptor did not affect the action of C-6-ceramide on I-Na. Intracellular application of the G-protein agonist GTP gamma S also induced a gradual decrease in I-Na amplitude, while the G-protein antagonist GDP beta S eliminated the effect of C-6-ceramide on I-Na. Calcium imaging showed that C-6-ceramide could give rise to a significant elevation of intracellular calcium. Our data show that increased calcium release through the IP3-sensitive Ca2+ receptor, which probably occurred through the G-protein and phospholipase C pathway, may be responsible for C-6-ceramide-induced inhibition of the INa of rat myoblasts.